4.7 Review

Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation Moving Hearts

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 71, 期 23, 页码 2691-2701

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.04.030

关键词

atrial fibrillation; fitness; cardiovascular disease; mHealth; mobile health; physical activity; prevention

资金

  1. Amazon
  2. AstraZeneca
  3. Bristol-Myers Squibb
  4. Medtronic
  5. AHA
  6. Apple
  7. Janssen
  8. Cardiva Medical
  9. Boehringer Ingelheim
  10. Abbott
  11. iRhythm
  12. Precision Health
  13. Amgen
  14. Bayer
  15. Gilead
  16. Merck
  17. MyoKardia
  18. Medicines Company
  19. CSL Limited
  20. GlaxoSmithKline
  21. Novartis
  22. Portola
  23. Sanofi

向作者/读者索取更多资源

The growing recognition that health takes place outside of the hospital and clinic, plus recent advances in mobile and wearable devices, have propelled the field of mobile health (mHealth). Cardiovascular disease and prevention are major opportunities for mHealth, as mobile devices can monitor key physiological signals (e.g., physical activity, heart rate and rhythm) for promoting healthy behaviors, detecting disease, and aid in ongoing care. In this review, the authors provide an update on cardiovascular mHealth by highlighting recent progress and challenges with mobile and wearable devices for assessing and promoting physical activity and fitness, and for monitoring heart rate and rhythm for the detection and management of atrial fibrillation. (C) 2018 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据